global healthcare Headline Latest Medicine Watch

Cheap Medicines Developed by "Virtual Clinical Trials" Revealed in Letter to Japanese Prime Minister

photograph of the IFPMA group with Japanese Prime Minister Shinzo Abe, Tokyo, Japan.

Current IFPMA group photograph with Japanese Prime Minister Shinzo Aben, Tokyo, Japan. Image Source.

"The Future of Health Care" as Designed by the Nice Vaccines and the Huge Pharma Billionaire International Elites, whose Companies Are Primarily Circling the World by

by MD Gary Kohls
Obligation to Warn online as we speak. It was addressed to Shinzo Abe, the Prime Minister of Japan, by the Conservative ("Liberal Democratic Party"), and was sent by the Worldwide Federation of Pharmaceutical Producers and Associations (IFPMA) (

Letter signed by IFPMA. Government Committee, consisting of the CEOs of Eli Lilllyn ($ 24 billion in revenue in 2018), Daiichi Sankyo of Japan ($ eight billion in income in 2018), UCB of Belgium ($ 27 billion in income in 2018) and Sanof in France ($ 42 billion in revenue) . in 2018). About 30 IFPMA members attending the Tokyo Tokyo assembly with Aben supported the letter (see photograph). Representatives (principally CEOs) of the worldwide pharmaceutical corporations pictured are listed on the backside of the letter.

One of many alarming objectives clearly proposed by IFPMA and expressed in Prime Minister Abe's letter is using public medical databases, Web know-how (as outlined under) and digital medical trials to "reduce drug development time and cost and increase probability of success."

(Word: The Web, which for some purpose was not defined in the letter to Abe, is outlined as: "The Web of Things, a system of interconnected computing, mechanical and digital machines, objects, animals, or people assigned a singular identifier (UID) info over the community without requiring human-to-human interaction or human-computer interaction. ”)

Right here is another associated problem on the IFPMA web site.

( leading-pharmaceutical-companies-current-industry-road-map-combat-antimicrobial resistance /)

IFPMA represents research-based pharmaceutical corporations and associations around the globe. The research-based pharmaceutical industry employs 2 million individuals to research, develop and ship medicines and vaccines that enhance patients' lives worldwide. IFPMA, based mostly in Geneva, has formal relationships with the United Nations and helps industry experience to assist the worldwide health group discover solutions that enhance international well being. "

The phrases and phrases in Bold and Italics in the letter are mine (GGK), however the words are those of the CEOs who signed the letter and are shown under. (Notice that these benefactors, none of whom are physicians and whose sole duty is to the income of their shareholders [and not to actual patients]aren’t your folks.)

Additionally word that this group of rich and highly effective sociopathic benefiters are quietly promoting public well being care, in order that they there have to be concrete plans to be sure that, in their future plans, all masked sufferers are utterly vaccinated with 270 vaccines in their developmental part, which, given the extent of vaccination and illiteracy of politicians, who’re also answerable for public well being, might occur.


IFPMA, Geneva, Switzerland – June three, 2019

Pricey Prime Minister Abe,

We are members of the Biopharmaceutical CEO Spherical Desk representing a worldwide R&D based mostly pharmaceutical firm. We’re dedicated to delivering revolutionary medicines / medical applied sciences all through the world, together with Japan, to build a vibrant society that permits individuals to stay longer, healthier and happier lives with out affected by new medicine.

We recognize your management in designating the biopharmaceutical industry as an essential strategic industry in Japan. For the upcoming G20 meetings in Japan, committed to promoting medical innovation, we welcome Japan's robust management worldwide, but in addition the subsequent three international well being points to meet our ultimate objective.

  1. The first level is that we nonetheless should not have enough dedication to well being methods that reinforce the aim of universal health coverage (UHC) – to guarantee entry to applicable health care at an inexpensive value – especially in creating nations.

We thank the Government of Japan (GOJ) for its continued help of the International Fund and the Gavi Alliance and its management in arranging the August Gavi Supplementary Facility. So far, the GOJ, as a part of its international leadership on healthy getting older, has strongly supported the transition to the UHC in the direction of the international group and has prioritized the health agenda as a topic in international fora (eg United Nations, G7 Summit, or TICAD).

Particularly, the GOJ reaffirmed the following needs on the UHC Forum 2017 in Tokyo:

1) strengthening the global momentum in the direction of the UHC,

2) creating and implementing a framework for cooperation at the ground degree,

three) continuous improvement monitoring,

] 4) securing sustainable financial assets for the UHC and

5) promoting innovation. Additionally, the G7's Ise-Shima vision reaffirms its significance. immunization throughout the life-cycle, as one of many key measures to forestall the unfold of communicable illness and to fight emerging pandemics.

We pharmaceutical corporations want to help Prime Minister Aben's robust leadership in these areas. We are additionally actively dedicated to figuring out our contribution to strengthening health techniques on our own initiative (accelerated access *) to convey together all related stakeholders.

Given the numerous limitations that remain, we should encourage particular person nations to take or strengthen measures to promote common health care. To this end, we look ahead to your continued help for mobilizing country-led processes for UHC, growing customization of individual efforts, and accelerating UHC objectives globally. Another facet is though many medical merchandise have thus far been obtainable to sure. in the remedy of illnesses, many different illnesses nonetheless wouldn’t have remedies, or ineffective or inadequate remedies.

This can be a widespread matter in each developed and creating nations. We, R&D based mostly pharmaceutical corporations, emphasize the value of partnership and consider that partnerships are a key factor in driving innovation.

The AMR (Anti-Microbial Resistance) Business Alliance Initiative **, a multi-stakeholder coordination surroundings addressing antimicrobial drug resistance worldwide public health concern, is simply an example.

Understanding and help of governments is crucial to facilitate innovation. We’re grateful in your commitment to help innovation as one of many five commitments talked about above. So as to ship on our commitment and ship revolutionary medicines to our sufferers, we make every effort to develop revolutionary medicines.

It’s critical to set up harmonized regulatory techniques in every nation, in addition to an enforceable remuneration system for progressive know-how. in specific, predictable and affordable safety of mental property rights.

Whereas some see the IP system as a barrier to access to medicines, the load of the evidence exhibits that focusing on pricing and mental property alone doesn’t produce. long-term profitable well being outcomes or improved entry to new medicines, they usually have to be linked to the core problems with the healthcare system.

  1. The third facet is the necessity to move to a new health care system that makes use of quite a lot of medical info, notably in mild of current advances in digital know-how similar to AI or massive knowledge and creating a legal framework that facilitates this improvement.

the modifications are additionally proceeding from the above two challenges:

1) accelerating the progress in the direction of UHC and

2) addressing unmet medical wants.

Japan established the National Health Insurance System (NHI) a long time in the past, and the huge amount of health and medical info collected beneath the NHI system can enable the achievement of the UHC in response to an getting older society via seamless coordination of preventive measures, early analysis, remedy, environment friendly use and optimization of well being care expenditure.

In addition, the transition to the brand new system would improve the utilization of real-world knowledge in revolutionary drug and know-how improvement, enabling the R&D pharmaceutical industry to find and develop revolutionary medicine quicker and extra efficiently. For example, use A mixture of a public medical database or IoT know-how and a digital medical trial can probably scale back drug improvement time and price and improve the probability of success.

Consequently, our revolutionary products may be delivered to patients in want of help in the past.

In summary, we’ll proceed our efforts to be a part of with others in accelerating in the direction of the UHC, addressing unmet medical needs, and reworking the New Healthcare System, which leverages quite a lot of medical knowledge to influence human well being globally.

We anticipate the Japanese leadership to steer constructive and evidence-based discussions on these international issues and to shape strategic policy selections inside and out of doors the G20. .

We look ahead to working with you to additional our objectives. Yours sincerely,

David A. Ricks Chairman and CEO Lilly and IFPMA Company Director and CEO

George Nakayama Chairman and CEO Daiichi. Sankyo Co. Ltd.

Jean-Christophe Tellier, Managing Director and Chairman of the Government Committee of UCB (Union Chimique Belge) SA

Dr. Olivier Brandicourt Managing Director Sanofi

Thomas Cueni Managing Director, IFPMA

* Accelerated Entry:

Access Accelerated brings together greater than 20 biopharmaceutical corporations committed to tackling the growing burden of communicable illnesses in low and middle revenue nations. Together with our partners, we create scalable and sustainable solutions to enhance individuals's well being.

** AMR Business Alliance:

AMR Business Alliance is among the largest personal sector alliances established to provide sustainable solutions to include. antimicrobial resistance, combining forces with over 100 biotechnology, diagnostics, generic and research-based drug corporations and associations. Kenji Yasukawa Managing Director Astellas Pharma Inc

Robert A. Bradway Chairman and Managing Director Amgen Inc. Michel Vounatsos Managing Director Biogen Inc.

Hubertus von Baumbach Managing Director Boehringer Ingelheim Chairman of the Board.

Tatsuro Kosaka, CEO of Chugai Pharmaceutical Co., Ltd

Werner Baumann, Chairman of the Board and CEO of Bayer AG

Haruo Naito, Consultant of KBECEO Corporate Director and CEO of Eisai Co., Ltd

Giovanni Caforio Managing Director Bristol-Myers Squibb

DR. F. Hoffmann-La Roche AG, Managing Director, Severin Schwan

Debora Dunsire Managing Director, H. Lundbeck A / S

Hiroshi Nomura Managing Director, Sumitomo Dainippon Pharma Co., Ltd

Mark J. Alles Chairman, Managing Director Celgene Company

] Albert Bourla Managing Director Pfizer Inc

Danial O & # 39; Day Chairman and Managing Director Gilead Sciences Inc

Kenneth C. Frazier Chairman Managing Director Merck & Co., Inc.

Olivier Laureau Managing Director Servier Group

. Christophe Weber Managing Director Takeda Pharmaceutical Co. Ltd

. Isao Teshirogi Managing Director Shionogi & Co., Ltd

Vas Narasimhan Managing Director Novartis AF

Dr. Eric Cornut Chairman Menarini Industrie Farmaceutiche Riunite

Dr. Jorge Gallardo President Almirall

Kåre Schultz Managing Director TEVA Pharmaceutical Ltd. / S

Emma Walmsley Managing Director GlaxoSmithKline, UK

Dr. Stefan Oschmann Chairman and CEO Merck KGaA

David Meek CEO IPSEN Pharmaceutical

Joaquin Duato Vice President Johnson & Johnson

More concerning the International Health Plan

medicine and vaccines that not use real randomized, double-blind, placebo-controlled, long-term medical trials – and solely use more efficient, cost-effective "virtual", computer-based "studies". A new daring world. GGK

IFPMA welcomes seven new members – August 24, 2015

IFPMA welcomes seven new members members new members. These are full members Shionogi & Co Ltd and Shire, associate members BIO and INTERPAT, and associate members of the Pharmaceutical Security Institute (PSI), the International Congress of Medicines Advisory Affiliation (IPCAA) and the Worldwide Federation of Pharmaceutical Distributors (IFPW). 19659005] Learn more about their actions

  • Shionogi & Co. Ltd is a pharmaceutical firm headquartered in Osaka, Japan. For over 135 years, Shionogi has been dedicated to creating medicines that shield the health and well-being of sufferers worldwide. Fulfilling unmet medical needs and enhancing the standard of lifetime of patients and their households information our company, our philosophy, and our group.
  • Shire focuses on creating and delivering revolutionary medicines to patients with rare illnesses and other special circumstances. This may be remedy for a really rare and life-threatening illness corresponding to Hunter's syndrome or Fabry's illness, or a remedy for particular circumstances reminiscent of ADHD or ulcerative colitis.
  • BIO is the world's largest trade association representing biotechnology corporations. , educational establishments, governmental biotechnology centers, and related organizations in the USA and over 30 different nations. BIO members are concerned in research and improvement of progressive biotechnology merchandise for health, agriculture, industry and the setting. BIO also produces the BIO International Conference, the world's largest assortment of biotechnology industries, as well as industry-leading investor and associate meetings held around the globe.
  • INTERPAT is an association of research-based pharmaceutical corporations. Its members embrace European, Japanese and US headquarters, that are dedicated to creating and delivering revolutionary medicines to sufferers around the globe. It’s represented by senior executives liable for patent and associated intellectual property in member companies.
  • The Pharmaceutical Safety Institute (PSI) is a non-profit group whose mission is to shield public health and disseminate info on counterfeiting of medicines. medicines and initiating enforcement actions via the competent authorities.
  • The Worldwide Congress of Medicines Congress (IPCAA) is a non-profit group that focuses on congressional administration. It seeks to improve industry requirements and protocols and offers member corporations with a variety of providers similar to coaching, codes of conduct and steerage. Internationally lively well being corporations that take part in medical congresses might be a part of the association. All member corporations should keep a permanent healthcare-oriented analysis program.
  • Worldwide Pharmaceutical Pharmaceutical Wholesalers (IFPW) is a worldwide commerce association that represents a full service pharmaceutical wholesaler and distributor. Its mission is to assist members and stakeholders promote the protected, effective and steady availability of medicines globally by promoting good distribution practices and providers.

Touch upon this article on

About Writer [19659005] DR. Kohls is a retired physician from Duluth, MN, USA. Throughout his pre-retirement years, he practiced what might greatest be described as "holistic (non-medical) and preventive mental health care." publication weekly.

His columns deal principally with American imperialism, friendly fascism, corporatism, militarism, racism and Massive Pharma, psychiatric medicine, childhood additional vaccinations and different movements that threaten US democracy, risks, kindness, health, longevity.

Lots of his columns have been archived at, http: //www.globalresearch. ca / writers? question = Gary + Kohls + articles & authored = & p = & page_id = or at

It can be reached at: ggkohls @

 healing from vaccines ad

  andrew_moulden_every_vaccine_produces_harm_e book2

  ascending from the dead

Order Right here!

Leaving the career of a lucrative nephrologist (kidney doctor), Dr. Suzanne Humphries can now truly help heal individuals. In his autobiography, he explains why, in the current corrupt medical system, good docs are limited to working towards true, ethical drugs. dared to talk about him publicly.


E-book – Vaccination Courtroom, by Wayne Rohde – 240 pages.


STATUS HERE! right here!

Make a press release about health freedom!

Huge Pharma and state health authorities try to move legal guidelines that pressure vaccines on all youngsters and even adults.

Present my opposition to pressured vaccinations and help the cause of vaccinations. Vaccine Influence, part of the Health Impression Information community.

Order Right here!

Revealed August 20, 2019

! -Perform (f, b, e, v, n, t, s)
If (f.fbq) return; n = f.fbq = perform () n.callMethod?
n.callMethod.apply (n, arguments): n.queue.push (arguments);
its (! f._fbq) f._fbq = n; n.push = n; n.loaded =! 0; n.model = & # 39; 2.0 & # 39 ;;
n.queue = []; t = b.createElement (e); t.async =! 0;
t.src = v; s = b.getElementsByTagName (e) [0];
s.parentNode.insertBefore (t, s) (window, doc, & # 39; script,
& # 39; https: //join.facebook.internet/en_US/fbevents.js');
fbq (& # 39; init & # 39 ;, & # 39; 928755773879843 & # 39;);